Concurrent Nivolumab-Induced Gastritis and Cholangitis Accompanied by Biliary Tract Hemorrhage in a Patient With Stage IV Lung Adenocarcinoma
2023 · Cureus · 3 citations
https://doi.org/10.7759/cureus.46392
A
Akihiro Tsukaguchi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
19
Citations
3
h-index
0
i10-index
Akihiro Tsukaguchi is an academic researcher from NHO Kinki Chuo Chest Medical Center. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Diagnosis and Treatment. The author has an h-index of 3, co-authored 17 publications.
ORCID: 0009-0009-6296-4386Papers by this author
worksReal‐World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in Japan
2025 · Thoracic Cancer · 3 citations
https://doi.org/10.1111/1759-7714.70047
672P Association between the administration time and therapeutic effect of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study
2024 · Annals of Oncology · 2 citations
https://doi.org/10.1016/j.annonc.2024.10.705
Supplementary Material for: Successful Dasatinib Treatment of Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma and BCR-ABL1-Positive Chronic Myeloid Leukemia: A Case Report
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21641615
Case of a rare EGFR mutation L747P identified using the lung cancer compact Panel™ leading to successful Afatinib treatment
2025 · Respiratory Medicine Case Reports · 0 citations
https://doi.org/10.1016/j.rmcr.2025.102255
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat